Browsing: Mortality Risk

At the end of June, the Continuous Mortality Investigation in the UK, which produces mortality data and analysis, issued its latest update, CMI_2024, which showed an increase in cohort life expectancies at age 65 in England and Wales.

The report, which covers the period 2024/2025, analyses data received from market leaders across 13 countries internationally across Europe, North America and Australia with established or developing equity release markets and explores their growth potential.

General mortality trend in England continues downwards but certain diseases getting worse.

Advances in early detection and treatment have significantly improved survival outcomes, especially in non-metastatic cases. However, prognosis varies greatly depending on the stage at diagnosis, molecular characteristics, and the extent of metastasis.

Life Risk News Q&A: Matthew Sheridan of Health Data Analytics Institute to get his thoughts on how predictive modelling is helping US health systems to better triage patients and model risk.

In a rare bright spot for the product, growth was observed in the 61+ age cohort.

During March, the estimated cost to transfer retiree pension risk to an insurer in a competitive bidding process climbed from 101.7% to 102.5% of a plan’s accounting liabilities.

Gokul Sudarsana, Chief Investment Officer of HSCM’s Life strategy and Co-Chief Investment Officer of the Firm’s Re/Insurance strategy.

Those still trying to understand any potential future impact of Covid-19 on mortality are conducting an exercise in futility.

The International Capital Standard (ICS) introduces a new approach to discounting illiquid liabilities — one that includes an explicit credit risk premium. But how does it compare to Solvency II’s Fundamental Spread? And what might it mean for UK insurers already familiar with the Matching Adjustment?